Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Change in Cash (2016 - 2025)

Historic Change in Cash for Rockwell Medical (RMTI) over the last 17 years, with Q3 2025 value amounting to $1.1 million.

  • Rockwell Medical's Change in Cash rose 13747.37% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year decrease of 7222.1%. This contributed to the annual value of $6.7 million for FY2024, which is 69687.22% up from last year.
  • As of Q3 2025, Rockwell Medical's Change in Cash stood at $1.1 million, which was up 13747.37% from $1.1 million recorded in Q2 2025.
  • Over the past 5 years, Rockwell Medical's Change in Cash peaked at $20.9 million during Q2 2022, and registered a low of -$17.8 million during Q3 2022.
  • Its 5-year average for Change in Cash is -$1.8 million, with a median of -$1.9 million in 2023.
  • As far as peak fluctuations go, Rockwell Medical's Change in Cash soared by 73287.84% in 2022, and later plummeted by 39558.08% in 2024.
  • Rockwell Medical's Change in Cash (Quarter) stood at -$10.1 million in 2021, then skyrocketed by 71.53% to -$2.9 million in 2022, then surged by 142.53% to $1.2 million in 2023, then soared by 171.57% to $3.3 million in 2024, then crashed by 66.06% to $1.1 million in 2025.
  • Its last three reported values are $1.1 million in Q3 2025, $1.1 million for Q2 2025, and -$4.3 million during Q1 2025.